Mesalazine Therapy in Patients With Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Mesalazine is effective in the treatment of
the abdominal discomfort or pain of Irritable Bowel Syndrome patients.